Home > What we do > Medicine & Healthcare > hMedicine > hMedicine Story

Going Local: Heads of Hadassah’s ERs Forge Bond with Community Pediatricians

Photo by Hadassah International

To bridge the gaps between pediatric emergency room (ER) and community medical care, heads of Hadassah’s emergency services reached out to neighborhood physicians and medics to share information and initiate a dialogue.

Dr. Saar Hashavya, who heads Pediatric Emergency Services at Hadassah’s Hospital in Ein Kerem, and Chief Emergency Room Nurse Pnina Sharon, as well as Prof. Eitan Kerem, head of Hadassah’s Pediatrics Division, saw this as an opportunity to get feedback from community doctors and medics who routinely care for Jerusalem’s youngsters. They wanted to let them know about the care Hadassah provides once their patients reach the ER. Hadassah's pediatric emergency rooms treat over 30,000 patients every year. The message Hadassah’s experts sought to convey was, "We're here for you and we want you to feel part of Hadassah," explains Dr. Hashavya.

“Hadassah's roots are in community medicine, and we feel good joining hands with the larger Jerusalem community," he added. "That means that when doctors refer a patient to us, we want to report back to them, both with our initial findings and follow-up." Among the Hadassah specialists who addressed the group were a pediatric neurosurgeon, cardiologist, dermatologist, emergency care physician, and an intensive care specialist. Diverse topics were covered, including screening children at risk, heart problems in children, new thinking in regard to epilepsy, as well as snake and insect bites. The topics had been suggested by community and drop-in clinic physicians, as well as health care professionals who care for patients in the ambulance.

"Our relationship with the community pediatricians is of key importance,” comments Prof. Kerem. “We would like them to use Hadassah Pediatrics as a resource for their daily activities and in emergency situations. Likewise, we have a lot to learn from them about what is happening in the community."

Date: 6/11/2014

Hadassah Stem Cell Expert Speaks at TEDx Conference in Jaffa

FDA Grants Approval for US Clinical Trials of Hadassah-Developed Technology to Treat Fatty Liver Disease

Hadassah Physicians Receive Prestigious Grants and Awards

New Research at Hadassah: Computational Tools Unravel the Mystery of Transient Amnesia

From Life-Threatening Brain Bleed to Birth of a Daughter

Cookbook Author, Rabbi Marks, Spends Last Days at Hadassah's Hospice

Hadassah’s Revolutionary Tipat Halav Clinics of 1920s Featured in Jerusalem Old City Museum

Victims of Terror Share Their Stories of Anguish and Appreciation with Hadassah President

Hadassah’s Advanced Gene Sequencing Changes the Life of a Family from Uzbekistan

IDF Medic Heroically Battles Terrorist, Both Treated at Hadassah

Orthopedic Trauma Turns Tragedy into Innovation at Hadassah

On the Cutting-Edge of Melanoma Treatment: Hadassah’s Protocols and Research

Saving a Newborn from a Life Without Sight

Terrorist and Victim Sent to Hadassah's Hospitals After Third Attack in Two Weeks

Three Sent to Hadassah After Second Jerusalem Terror Attack of the Week

Clinical Trial of Hadassah-Developed Stem Cell Treatment for Macular Degeneration Gets Go-Ahead from FDA

“We Don’t Say ‘No’,” Hadassah Neurosurgeon Explains in Operating on 82-Year-Old Patient

Cutting-Edge Medicine and Research; a Role Model for Peace: A Briefing from the Hospital's Director General

4 Ways Hadassah Hospital is Preparing for Ebola—Just in Case

Hailing from 17 Countries: the 39th Graduation Class of Hadassah’s International Master of Public Health Program

More hMedicine Stories

Hadasit, Hadassah’s Technology Transfer Arm, Reviews 2012’s Accomplishments

When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential. Although 2012 has been “a year full of challenges for the life science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer, Hadasit still signed 125 agreements for clinical trials, all to be done at Hadassah. In addition, Hadasit signed 15 agreements for cooperation and commercialization of technologies that were developed at Hadassah. Click here to read the latest Newsletter from Hadasit >>

   |  Who We Are  |  What We Do  |  Where We Do It  |  Read About It  |  Join Now  |  Donate  |
  |  Login  |  Contact Us  |  Careers  |  Terms & Conditions  |  
Copyright ©2014 Hadassah is a registered trademark of Hadassah, the Women's Zionist Organization of America